Back to Agenda
IMPROVING CLINICAL DEVELOPMENT PERFORMANCE
Session Chair(s)
Estrella Garcia, PhD
Head of Global Clinical Operations
Almirall S.A., Spain
Learning Objective : • Describe the framework for minimizing and managing protocol deviation in a clinical trial • How best to classify/categorize protocol deviations as Critical, Major, Minor or using other groupings • Collaborate on a risk reduction strategy
Speaker(s)
TransCelerate as an Industry Driven Performance Initiative – Start-up, launch and year one
Kathleen Ford, BSN, RN
Merck KGaA, Germany
Senior Vice President, Head of Global Clinical Operations
Position Paper "Life-cycle and Management of Protocol Deviations”
Katharina Kurpanek, MSc
The QM Company, Belgium
Torsten Friedel, MSc, PMP
intilaris LifeSciences GmbH, Switzerland
Managing Director
Have an account?